yingweiwo

PCSK9

PCSK9

PCSK9 related products

Structure Cat No. Product Name CAS No. Product Description
(R,R)-PCSK9 degrader 1 V87650 (R,R)-PCSK9 degrader 1 2216703-12-5 (R,R)-PCSK9 degrader 1 is an isomer of PCSK9 degrader 1.
7030B-C5 V98991 7030B-C5 370871-42-4 7030B-C5 is a PCSK9 inhibitor (IC50=1.61 μM).
AZD8233 V87653 AZD8233 2604215-74-7 AZD8233 is a liver-targeting antisense oligonucleotide that inhibits proprotein convertase/subtilisin 9 (PCSK9) protein synthesis.
AZD8233 sodium V87655 AZD8233 sodium AZD8233 sodium is a liver-targeted antisense oligonucleotide that inhibits proprotein convertase/subtilisin/kexin type 9 (PCSK9) protein synthesis.
BRD8518 V98901 BRD8518 1565828-01-4 BRD8518 is a PCSK9 inhibitor (EC50=0.23 μM).
Cepadacursen sodium V87646 Cepadacursen sodium 2252375-14-5 Cepadacursen sodium is a liver-targeted antisense oligonucleotide that inhibits proprotein convertase/subtilisin/kexin type 9 (PCSK9) protein synthesis.
CVI-LM001 V87648 CVI-LM001 CVI-LM001 is a PCSK9 inhibitor that regulates the level of low-density lipoprotein cholesterol (LDL-C) in the blood by inhibiting the interaction between PCSK9 and low-density lipoprotein receptor (LDLR), thereby exerting a lipid-lowering effect.
DC371739 V87324 DC371739 2135765-21-6 DC371739 is a potent, orally active PCSK9 inhibitor.
E28362 V87654 E28362 930017-01-9 E28362 is a small molecule PCSK9 inhibitor.
MeIm V99540 MeIm 2043947-71-1 MeIm (compound 7) is a high-affinity PCSK9-targeting peptide mimetic with cholesterol-lowering activity.
PCSK9 allosteric binder-1 V99859 PCSK9 allosteric binder-1 2215932-06-0 PCSK9 Allosteric Binder-1 (Example 70) is a PCSK9 allosteric binder.
PCSK9-IN-26 V87649 PCSK9-IN-26 3033361-09-7 PCSK9-IN-26 (Compound 116) is a PCSK9 inhibitor (IC50 < 1 nM).
PCSK9-IN-27 V87651 PCSK9-IN-27 PCSK9-IN-27 (Compound 108) is a PCSK9 inhibitor (IC50: 3.4 nM).
PCSK9-IN-28 V87652 PCSK9-IN-28 PCSK9-IN-28 (Compound C11) is a PCSK9 inhibitor isolated from Euphorbia esula.
PCSK9-IN-29 V98057 PCSK9-IN-29 1233353-86-0 PCSK9-IN-29 is a lipid-lowering drug.
PCSK9-IN-30 V97401 PCSK9-IN-30 PCSK9-IN-30 (compound 3f) is a PCSK9 inhibitor.
PCSK9-IN-31 V99662 PCSK9-IN-31 2247649-76-7 PCSK9-IN-31 (compound WX002) is an orally available PCSK9 inhibitor.
PCSK9-IN-32 V94899 PCSK9-IN-32 PCSK9-IN-32 (Compound 8) is a PCSK9-GFP translation inhibitor.
PF-00932239 (R-IMPP) V6648 PF-00932239 (R-IMPP) 2133832-83-2 PF-00932239 (R-IMPP) is a novel and potent inhibitor of PCSK9 translation.
PF-06446846 hydrochloride V27359 PF-06446846 hydrochloride 1632250-50-0 PF‑06446846 HCL (PF-6446846;PF6446846) is a PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitor with anti-hyperlipidemic effects.
Contact Us